The<unk> , founded in 2015, is an independent group of international experts that bring together key professionals, groups and government officials to deal with issues related to screening and<unk>  programmes for human papillomavirus <unk>  infection, the persistence of which may lead to cervical cancer, the second most common cancer in women living in low-resource settings. The<unk>  focusses on<unk> g cervical cancer in these countries by promoting the sharing of information on cervical screening and<unk>  vaccination, which by 2014 had reached only around 3% of eligible girls in low income countries. The<unk>  is located at the Vaccine and Infectious Disease Institute of the University of Antwerp and its website is a member of the World Health Organization (WHO) led project Vaccine Safety Net (VSN). Local policy-makers can take advice and assistance from the<unk>  on introducing and extending programmes, and by taking into consideration recommendations by the WHO, the<unk>  can facilitate political backing required for their application. One example of their work was in 2018 when the<unk>  contributed to efforts to regain confidence in vaccines for cervical cancer in Columbia following a sudden nationwide drop in uptake of the vaccine's first and second dose from 98% and 88% in 2012 to 14% and 5% in 2016.
HPV Prevention and Control Board
BC Cancer Agency
FinnProstate Group
Blood Cancer UK
Foundation doctor
Ova bank
Biological and Pharmaceutical Bulletin
HIV/AIDS Bureau